Baker Bros. Advisors »

Lb Pharmaceuticals shares owned by Baker Bros. Advisors

Quarter-by-quarter ownership of Lb Pharmaceuticals shares owned by Baker Bros. Advisors from 13F filings

Historical chart of Baker Bros. Advisors investment in Lb Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Lb Pharmaceuticals held by Baker Bros. Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lb Pharmaceuticals by Baker Bros. Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.2M 200k 15.79

More positions owned by Baker Bros. Advisors

BeOne Medicines Sponsored Ads (ONC)
Incyte Corporation (INCY)
Madrigal Pharmaceuticals (MDGL)
Insmed Incorporated Com Par $.01 (INSM)
ACADIA Pharmaceuticals (ACAD)
Summit Therapeutics (SMMT)
Rhythm Pharmaceuticals (RYTM)
Revolution Medicines (RVMD)
Celcuity (CELC)
Kymera Therapeutics (KYMR)
Kodiak Sciences (KOD)
Alkermes SHS (ALKS)
Abcellera Biologics (ABCL)
Edgewise Therapeutics (EWTX)
Kiniksa Pharmaceuticals International Ord Shs Cl A (KNSA)

View all positions for Baker Bros. Advisors

Top funds holding Lb Pharmaceuticals

Deep Track Capital
RA Capital Management
TCG Crossover Management
Commodore Capital
Logos Global Management
Jpmorgan Chase & Co
BlackRock
Balyasny Asset Management
Vivo Capital
Jennison Associates
Alyeska Investment Group
Nantahala Capital Management
Citadel Advisors
Millennium Management
Soleus Capital Management

View all funds holding Lb Pharmaceuticals